Optimizing end points and outcomes in cancer-associated wasting.
Dahele
M
M
Wall
L
L
D001066:Appetite / Q000187:drug effects; D019167:Appetite Stimulants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D015118:Eicosapentaenoic Acid / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D023381:Endpoint Determination; D006801:Humans; D019290:Megestrol Acetate / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D009369:Neoplasms / Q000150:complications*; D015203:Reproducibility of Results; D019282:Wasting Syndrome / Q000188:drug therapy* / Q000209:etiology*; D015430:Weight Gain
D019167:Appetite Stimulants; D015118:Eicosapentaenoic Acid; D019290:Megestrol Acetate